Could cause temporary or reversible harm; serious harm is unlikely.
CMGP Deviations: Presence of NDMA impurity detected in product and exceed the Acceptable Daily Intake Limit (ADI) of 96ng/day.
| Distributed by / for | Preferred Pharmaceuticals, Inc. |
| NDC | 68788-6932-1 |
| Full product label | Preferred Pharmaceuticals Inc., Metformin HCl, Extended Release Tab. USP 500 mg, Generic for Glucophage XR, Rx Only, Pkg Size: 100, Mfg: Time-Cap Labs Inc.; Farmingdale NY, NDC #: 68788-6932-1 |
| Recalling firm | Preferred Pharmaceuticals, Inc. |
| Distribution | Distributed to two physician consignees located in FL. |
| Quantity | 147 bottles (14,700 extended release tablets) |
| Recall initiated | 2021-04-28 |
| Report date | 2021-05-26 |
| Recall completed | — |
| Recall number | D-0385-2021 |
| Classification | Class II |
| FDA status | Ongoing |
| Origin on file | Anaheim CA United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗